JIC
NEO icon

Johnson Investment Counsel’s NeoGenomics NEO Stock Holding History

Johnson Investment Counsel’s Portfolio NEO Stock Details NEO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-12,235
Closed -$89.4K – 860
2025
Q2 		$89.4K Buy
12,235
+1,329
+12% +$10.7K ﹤0.01% 803
2025
Q1 		$103K Buy
10,906
+700
+7% +$8.74K ﹤0.01% 785
2024
Q4 		$168K Buy
+10,206
New +$159K ﹤0.01% 769

Other funds holding NEO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return
GF
Greenhouse Funds Baltimore, Maryland $2.23B AUM 12.38% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Johnson Investment Counsel's NEO Position: Q3 2025 in Review

Johnson Investment Counsel sold out of NeoGenomics (NEO) in Q3 2025, closing a stake of 12,235 shares — an estimated $89.4K sold.

Johnson Investment Counsel first reported a position in NEO in Q4 2024 and held it in 3 quarters. The position peaked at $168K in Q4 2024. 254 funds tracked by Wall St. Rank hold NEO as of Q3 2025.

  • Johnson Investment Counsel reported no remaining NeoGenomics position as of Q3 2025 after selling out during the quarter.
  • Johnson Investment Counsel sold 12,235 NeoGenomics shares in Q3 2025, an estimated $89.4K.
  • Johnson Investment Counsel first reported a position in NeoGenomics in Q4 2024 and held it in 3 quarters.
  • Johnson Investment Counsel's NeoGenomics position peaked at $168K in Q4 2024.
  • 254 funds tracked by Wall St. Rank held NeoGenomics as of Q3 2025.

Based on Johnson Investment Counsel's 13F filing for Q3 2025, filed 6 Nov 2025.